SII
- India
DCGI to review applications of Bharat Biotech, SII for full market approval to Covaxin, Covishield today
New Delhi: Drugs Controller General of India (DCGI)’s Subject Expert Committee will review applications of Bharat Biotech and Serum Institute of India (SII) for full market approval to Covaxin and Covishield respectively…